Efficacy and safety study of high-dose versus low-dose Yukon sirolimus-eluting stent in diffuse coronary artery disease.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Sirolimus (Primary)
- Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial infarction; Unstable angina pectoris
- Focus Therapeutic Use
- 23 Aug 2011 New trial record